User menu

La rapamycine ouvre l’ère des thérapies ciblées dans les malformations veineuses

Bibliographic reference Seront, Emmanuel ; Limaye, Nisha ; Boon, Laurence ; Vikkula, Miikka. La rapamycine ouvre l’ère des thérapies ciblées dans les malformations veineuses. In: M/S : médecine sciences, Vol. 32, no. 6-7, p. 574-578 (2016)
Permanent URL http://hdl.handle.net/2078.1/181324
  1. Dompmartin A, Vikkula M, Boon L M, Venous malformation: update on aetiopathogenesis, diagnosis and management, 10.1258/phleb.2009.009041
  2. Suri Chitra, Jones Pamela F, Patan Sybill, Bartunkova Sona, Maisonpierre Peter C, Davis Samuel, Sato Thomas N, Yancopoulos George D, Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis, 10.1016/s0092-8674(00)81813-9
  3. Laplante Mathieu, Sabatini David M., mTOR Signaling in Growth Control and Disease, 10.1016/j.cell.2012.03.017
  4. Korpelainen Eija I, Kärkkäinen Marika, Gunji Yuji, Vikkula Miikka, Alitalo Kari, Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response, 10.1038/sj.onc.1202288
  5. Limaye Nisha, Wouters Vinciane, Uebelhoer Melanie, Tuominen Marjut, Wirkkala Riikka, Mulliken John B, Eklund Lauri, Boon Laurence M, Vikkula Miikka, Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations, 10.1038/ng.272
  6. Uebelhoer Melanie, Nätynki Marjut, Kangas Jaakko, Mendola Antonella, Nguyen Ha-Long, Soblet Julie, Godfraind Catherine, Boon Laurence M., Eklund Lauri, Limaye Nisha, Vikkula Miikka, Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB, 10.1093/hmg/ddt198
  7. Boscolo Elisa, Limaye Nisha, Huang Lan, Kang Kyu-Tae, Soblet Julie, Uebelhoer Melanie, Mendola Antonella, Natynki Marjut, Seront Emmanuel, Dupont Sophie, Hammer Jennifer, Legrand Catherine, Brugnara Carlo, Eklund Lauri, Vikkula Miikka, Bischoff Joyce, Boon Laurence M., Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects, 10.1172/jci76004
  8. Limaye Nisha, Kangas Jaakko, Mendola Antonella, Godfraind Catherine, Schlögel Matthieu J., Helaers Raphael, Eklund Lauri, Boon Laurence M., Vikkula Miikka, Somatic Activating PIK3CA Mutations Cause Venous Malformation, 10.1016/j.ajhg.2015.11.011
  9. Julien Louis-André, Roux Philippe P., mTOR, la cible fonctionnelle de la rapamycine, 10.1051/medsci/201026121056
  10. Sarbassov Dos D., Ali Siraj M., Sengupta Shomit, Sheen Joon-Ho, Hsu Peggy P., Bagley Alex F., Markhard Andrew L., Sabatini David M., Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB, 10.1016/j.molcel.2006.03.029